BioSpace News Archive

SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of percutaneous peripheral nerve stimulation for patients with recurrent low back pain who underwent a radiofrequency ablation procedure at least six months prior.

Jake Snee is joining BioDerm as their new Vice President of Sales and Marketing. Snee brings over fifteen years of Healthcare sales experience to his new position.

Emmaus Life Sciences, Inc. (OTC: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that it has entered into an agreement with Kainos Medicine, Inc. (“Kainos”) to lead the preclinical development of Kainos’ patented IRAK4 inhibitor (KM10544) as an anti-cancer drug

Sitchon to highlight S1 Biopharma focus on central nervous system role in issues associated with sexual function and sexual wellness.

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dosing safety and efficacy data for poziotinib from Cohort 5 of the ZENITH20 clinical trial. These preliminary data demonstrate improved tolerability with BID dosing, reduced dose interruption compared to once daily (QD) dosing

A new patent is poised to help migraine sufferers. Scientists have been searching for a brain wave test for migraine for 75 years, but the signals were too complicated to decode until the recent application of machine learning.

The provisional patent applications include data derived from NeonMind’s initial preclinical trial that began in November 2020, which examined the potential use of psilocybin as a treatment for weight loss.

Amplifon is proud to celebrate World Hearing Day, confirming its commitment to the treatment and prevention of hearing loss, a condition that impacts nearly 40 million Americans.

CHOP/Penn study shows T cell activation in children with MIS-C more similar to adults with severe COVID-19

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imaging and therapeutic applications, today announced that Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes, will present at the H.C. Wainwright Global Life Sciences Conference,